US Broker Ratings

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: 22% Potential Upside Amidst Innovative Gene Therapy Developments

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, stands out with its innovative approach to rare disease treatment. Focused on RNA-targeted therapeutics and gene therapy, Sarepta..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 22.56% Potential Upside on Robust Analyst Confidence

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a Boston-based biotechnology firm, is making waves in the healthcare sector with a promising pipeline targeting rare neuroendocrine diseases. With a market capitalization of $7.95..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Potential 48% Upside Sparks Investor Interest

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is stirring significant interest among investors with its promising pipeline of muscle activators and inhibitors aimed at treating debilitating..

AptarGroup, Inc. (ATR) Investor Outlook: Potential 28.8% Upside Sparks Interest

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a compelling potential upside of 28.8%...

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring the 15.87% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $9.83 billion, this U.S.-based company is making..

Guardant Health, Inc. (GH) Stock Analysis: A 23.59% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, a field that is gaining significant traction as technological advancements continue to redefine cancer diagnostics and..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Sleep Apnea Market with a 5.78% Upside Potential

Inspire Medical Systems, Inc. (INSP) is a key player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, the company has been at the..

The Ensign Group, Inc. (ENSG) Investor Outlook: Analyzing 21.11% Potential Upside Amid Healthcare Expansion

The Ensign Group, Inc. (NASDAQ: ENSG), a leader in the healthcare sector, primarily operating within the medical care facilities industry, presents a compelling opportunity for investors seeking growth combined with..

United Therapeutics Corporation (UTHR) Stock Analysis: Potential 30% Upside Captivates Investors

United Therapeutics Corporation (NASDAQ: UTHR) is currently capturing the attention of individual investors with a promising potential upside of 30.72%. Operating in the healthcare sector, United Therapeutics specializes in developing..

Bruker Corporation (BRKR) Stock Analysis: A Close Look at Its 1.82% Potential Upside Amidst Healthcare Sector Dynamics

As the healthcare sector continues to evolve with groundbreaking innovations, Bruker Corporation (NASDAQ: BRKR) stands out as a pivotal player within the medical devices industry. With a market capitalization of..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with 141.76% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a significant player in the biotechnology sector, attracting attention with its innovative approach to cell therapies, particularly in oncology. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: Evaluating Growth Potential with a 7.79% Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing investment opportunity for those eyeing growth and stability...

Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the healthcare plans industry, has caught the attention of investors with its robust market presence and promising growth metrics. With a market..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling an 18% Potential Upside amid Robust Revenue Growth

Corcept Therapeutics Incorporated (NASDAQ: CORT), a noteworthy player in the biotechnology industry, is capturing investor attention with its promising growth metrics and significant upside potential. With a market capitalization of..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling Growth Potential with a 9.84% Upside

TransMedics Group, Inc. (TMDX) stands as a pioneering force in the healthcare sector, specifically within the medical devices industry. This U.S.-based company has carved a niche for itself through its..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a Volatile Journey in TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based firm specializing in Traditional Chinese Medicine (TCM), presents a unique investment opportunity within the healthcare sector. Despite the lack of a..

RadNet, Inc. (RDNT) Stock Analysis: A 21.64% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Los Angeles, California, RadNet has carved a niche..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a Potential 43% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. Founded in 1993 and headquartered in Morrisville, North Carolina,..

Glaukos Corporation (GKOS) Stock Analysis: Assessing Growth Potential Amid a Robust Revenue Surge

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its significant market presence and promising growth trajectory...

CVS Health Corporation (CVS) Stock Analysis: Navigating a 19.47% Potential Upside with Robust Revenue Growth

CVS Health Corporation (NYSE: CVS), a heavyweight in the healthcare sector, is capturing investor attention with a compelling proposition of a 19.47% potential upside according to recent analyst ratings. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds